Cytokine gene polymorphisms associating with severe acute graft-versus- host disease in HLA-identical sibling transplants

Blood

Volumn 92, Issue 10, 1998, Pages 3943-3948

  Middleton, Peter G ^a   Taylor, Penelope R A ^b   Jackson, Graham ^b   Proctor, Stephen J ^b   Dickinson, Anne M ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; INTERLEUKIN 10; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; GRAFT VERSUS HOST REACTION; HLA TYPING; HOMOZYGOSITY; HUMAN; INCIDENCE; IRRADIATION; MALE; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

EID: 0032533678     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3943.422k35_3943_3948     Document Type: Article

References (33)

1. Daser A, Mitchison H, Mitchison A, Muller B: Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes, Cytokine 8:593, 1996
2. Krenger W, Hill GR, Ferrera JML: Cytokine cascades in acute graft-ver s us-host disease. Transplantation 64:553, 1997
3. Holler E, Ferrara JML: Antagonists of inflammatory cytokines: prophylactic and therapeutic applications, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft versus Host Disease. New York, NY, Dekker, 1997, p 667
4. Mayer FR, Messer G, Knabe W, Mempel W, Meurer M, Kolb HJ, Holler E: High response of TNFα secretion in vivo in patients undergoing BMT may be associated with the -308 bp TNF-α-gene enhancer-polymorphism. Bone Marrow Transplant 17:s101, 1996 (abstr)
5. Holler E, Ertl B, Hintermeier-Knabe R, Roncarolo MG, Eissner G, Mayer F, Fraunberger P, Behrends U, Pfannes W, Kolb HJ, Wilmanns W: Inflammatory reactions induced by pretransplant conditioning - An alternative target for modulation of acute GVHD and complications following allogeneic bone marrow transplantation? Leuk Lymphoma 25:217, 1997
6. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor a: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233, 1990
7. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW: Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1:353, 1992
8. Brinkman BMN, Giphart MJ. Verhoef A, Kaijzel EL, Naipal AMIH, Daha MR, Breedveld FC, Verweij CL: Tumour necrosis factor CK-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome, Hum Immunol 41:259, 1994
9. Abraham LJ, French MA, Dawkins RL: Polymorphic MHC haplotypes affect the activity of tumor necrosis factor alpha. Clin Exp Immunol 92:14, 1993
10. Udalova IA, Neclospasov SA, Webb GC, Chaplin DD, Turetskaya RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180, 1993
11. Holzinger I, de Baey A, Messer G, Kick G, Zwierzina H, Weiss EH: Cloning and genomic characterisation of LST1: A new gene in the human TNF region. Immunogenetics 42:315, 1995
12. Turner DM, Grant SCD, Lamb WR, Brenchley PEC, Dyer PA, Sinnott PJ, Huichinson IV: A genetic marker of high TNFα production in heart transplant recipients. Transplantation 60:1113, 1995
13. Roncarolo M-G: The role of interleukin-10 in transplantation and GVHD, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft versus Host Disease. New York, NY, Dekker. 1997, p 693
14. Korholz D, Kunst D, Hempel L, Sohngen D, Heyll A, Bonig H, Gobel U, Zintl F, Burdach S: Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 19:691, 1997
15. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV: Cytokine gene polymorphism and heart transplant rejection. Transplantation 64:776, 1997
16. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1, 1997
17. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H: Isolation of the human interleukin 10 promoter. Characterisation of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7:1, 1995
18. Ollerup O, Zetterquist H: HLA-DR typing by polymerase chain reaction amplification with sequence specific primers (PCR-SSP), in Hui K, Bidwell J (eds): Handbook of HLA Typing Techniques. Boca Raton, FL, CRC, 1993, p 225
19. Eskdale J, Gallagher G: A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 42:444, 1995
20. Ringden O, Deeg HG: Clinical spectrum of graft-versus-host disease, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft versus Host Disease. New York, NY, Dekker. 1997, p 525
21. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL: Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516, 1997
22. Wilson AG, de Vries N, van de Putte LB. Duff GW: A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 54:601, 1995
23. Fong KY, Wowe HS, Tin SK, Boey ML, Feng PH: Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 25:90, 1996
24. Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, Jewell D: Cytokine gene polymorphisms in inflammatory bowel disease. Gut 39:705, 1996
25. Clay FE, Cork MJ, Wilson AC, Crane AM, Lewis F, Harrington CI, Duff GW: Promoter region polymorphism in the human TNF-alpha gene is not associated with lichen sclerosus. Exp Dermatol 5:227, 1996
26. Verjans GM, Brinkman BM, Van Doornik CE, Kijlstra A, Verweij CL: Polymorphism of tumor necrosis factor-alpha (TNFα) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 97:45, 1994
27. Cox A, Gonzalez AM, Wilson AG, Wilson RM, Ward JD, Artlett CM, Welsh K, Duff GW: Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 37:500, 1994
28. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D: Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 12:127, 1995
29. Moffatt MF, Cookson WO: Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 6:551, 1995
30. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JHF, Vossen J, Gratwohl A, Vogelsang GB, von Houwelingen HC, van Rood JJ: Mismatches of minor histocompalibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334:281, 1996
31. Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H: Host-specific interleukin-2 secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 327:1613, 1992
32. Dickinson AM, Sviland L, Jackson G, Usher P, Taylor P, Dunn J, Hamilton PJ, Proctor SJ: Cytokine involvement in predicting clinical graft versus host disease (GVHD) in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 13:65, 1994
33. Sviland L, Dickinson AM, Carey PJ, Pearson ADJ, Proctor SJ: An in vitro predictive test for clinical graft versus host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 5:105, 1990